MIOCHOL-E Powder and solvent for instillation solution Ref.[6058] Active ingredients: Acetylcholine

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2014  Publisher: DR GERHARD MANN CHEM-PHARM FABRIK GMBH BRUNSBUTTELER DAMM 165-173 13581 BERLIN GERMANY

Therapeutic indications

To obtain rapid and complete miosis after delivery of the lens in cataract surgery as well as in penetrating keratoplasty, iridectomy and other anterior segment surgery where rapid complete miosis is required.

Posology and method of administration

Miochol-E is for intraocular irrigation only. A freshly prepared 1% solution should be used in the anterior chamber of the eye during surgery.

Adults and Elderly

In most cases a satisfactory miosis, which will last for approximately 20 minutes, is produced in seconds by 0.5-2.0ml. A second application may be made at the discretion of the surgeon if prolonged miosis is required.

Children

Safety and effectiveness in children has not been established.

Route of administration

Intraocular irrigation during surgery.

Overdose

The symptoms of overdosage are likely to be effects resulting from systemic absorption, ie bradycardia, hypotension, flushing, breathing difficulties and sweating. Atropine sulphate (0.5-1mg) should be given intramuscularly or intravenously and should be readily available to counteract possible overdosage. Adrenaline (0.1-1mg subcutaneously) is also of value in overcoming severe cardiovascular or bronchoconstrictor responses.

Shelf life

Shelf life

Unopened: 24 months.

Opened: Use immediately after reconstitution.

Special precautions for storage

Do not store above 25°C. Do not freeze. Do not resterilise.

Nature and contents of container

Miochol-E is supplied as packs containing 1 blister and 1 filter hub.

Packs are subjected to antimicrobial treatment with ethylene oxide.

One blister contains:

  • vial containing powder; clear, colourless type 1 glass with rubber stopper and plastic cap.
  • ampoule containing solvent: clear, colourless type 1 glass ampoule with One Point cut (OPC).

One filter hub with 5 micron filter, luer lock (CE marking number: CE 0123)

Special precautions for disposal and other handling

The reconstituted preparation is a clear, colourless solution.

Warning: Do not use if blister or peelable backing is damaged or broken. Open under aseptic conditions only. The contents of the blister can be guaranteed as sterile.

Directions for preparing Miochol-E:

  1. Inspect unopened blister to ensure that it is intact. Peel open blister.
  2. Aseptically transfer the ampoule, vial and syringe tip filter hub to sterile field. Maintain asepsis during preparation of solution.
  3. Aseptically attach a sterile 18 to 20 gauge, bevelled needle to the luer tip of a sterile disposable syringe with twisting motion to assure secure fit.
  4. Break open the ampoule containing the solvent. The One Point Cut (OPC) ampoule must be opened as follows: Hold the bottom part of the ampoule with the thumb pointing to the coloured point. Grasp the top of the ampoule with the other hand, positioning the thumb at the coloured point and press back to break at the existing cut under the point.
  5. Remove the needle protector and withdraw the solvent from the ampoule into the syringe. Discard ampoule.
  6. Remove and discard plastic cap from top of vial.
  7. Insert the needle through the centre of the vial stopper.
  8. Transfer the solvent from the syringe to the vial.
  9. Shake gently to dissolve drug.
  10. Slowly withdraw the solution from the vial through the needle into the syringe.
  11. Discard needle.
  12. Aseptically open tip filter hub pouch.
  13. Aseptically attach filter hub onto luer tip of syringe with a twisting motion to assure secure fit.
  14. Aseptically attach a sterile blunt tip irrigation cannula to male luer of filter prior to intraocular irrigation.
  15. Discard appropriately after use. Do not reuse the filter hub.

The solution must be mixed just before use since aqueous solutions of acetylcholine are unstable. Only clear and colourless solutions should be used.

Miochol-E should not be re-sterilised. The filter hub is recommended only for use with Miochol-E. Aspiration through the filter is not recommended. However, if utilised, discard needle and syringe filter to prevent recontamination of fluids during injection.

Do not aspirate and inject through the same filter.

Do not use unless a clear and colourless solution is produced. For single use only. Discard any unused solution.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.